- Home
- LTRX vs TLSA Comparison
LTRX vs TLSA Comparison
Compare LTRX & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- TLSA
- Stock Information
- Founded
- LTRX 1989
- TLSA 2013
- Country
- LTRX United States
- TLSA United Kingdom
- Employees
- LTRX N/A
- TLSA N/A
- Industry
- LTRX Computer Communications Equipment
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- LTRX Telecommunications
- TLSA Health Care
- Exchange
- LTRX Nasdaq
- TLSA Nasdaq
- Market Cap
- LTRX 106.5M
- TLSA 87.8M
- IPO Year
- LTRX 2000
- TLSA 2000
- Fundamental
- Price
- LTRX $2.10
- TLSA $1.57
- Analyst Decision
- LTRX Strong Buy
- TLSA
- Analyst Count
- LTRX 5
- TLSA 0
- Target Price
- LTRX $5.60
- TLSA N/A
- AVG Volume (30 Days)
- LTRX 216.2K
- TLSA 460.2K
- Earning Date
- LTRX 05-08-2025
- TLSA 05-20-2025
- Dividend Yield
- LTRX N/A
- TLSA N/A
- EPS Growth
- LTRX N/A
- TLSA N/A
- EPS
- LTRX N/A
- TLSA N/A
- Revenue
- LTRX $143,159,000.00
- TLSA N/A
- Revenue This Year
- LTRX N/A
- TLSA N/A
- Revenue Next Year
- LTRX $11.33
- TLSA N/A
- P/E Ratio
- LTRX N/A
- TLSA N/A
- Revenue Growth
- LTRX N/A
- TLSA N/A
- 52 Week Low
- LTRX $1.91
- TLSA $0.54
- 52 Week High
- LTRX $4.55
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- LTRX 42.72
- TLSA 64.57
- Support Level
- LTRX $2.10
- TLSA $1.49
- Resistance Level
- LTRX $2.30
- TLSA $1.78
- Average True Range (ATR)
- LTRX 0.12
- TLSA 0.18
- MACD
- LTRX 0.03
- TLSA 0.04
- Stochastic Oscillator
- LTRX 23.08
- TLSA 71.23
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.